The Value of Treating Opioid Use Disorder in Family Medicine: From the Patient Perspective

References

1. 1.↵
   National Academies of Sciences, Engineering, and Medicine. 2019. Medications for opioid use disorder save lives. Washington, DC: The National Academies Press.
2. 2.↵
   Substance Abuse and Mental Health Services Administration. 2019. Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health (HHS Publication No. PEP19-5068, NSDUH Series H-54). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/.
3. 3.↵
   1. Andrilla CHA,
   2. Coulthard C,
   3. Larson EH

   . Barriers rural physicians face prescribing buprenorphine for opioid use disorder. Ann Fam Med 2017;15:359–62.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Hutchinson E,
   2. Catlin M,
   3. Andrilla CHA,
   4. Baldwin L-M,
   5. Rosenblatt RA

   . Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12:128–33.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. DeFlavio JR,
   2. Rolin SA,
   3. Nordstrom BR,
   4. Kazal LA

   . Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians. Rural Remote Health 2015;15:3019.

   OpenUrl
6. 6.↵
   1. Nowell LS,
   2. Norris JM,
   3. White DE,
   4. Moules N

   . Thematic analysis: striving to meet trustworthiness criteria. Int J Qual Methods 2017;16:1–13.

   OpenUrl
7. 7.↵
   1. Hatcher AE,
   2. Mendoza S,
   3. Hansen H

   . At the expense of a life: race, class, and the meaning of buprenorphine in pharmaceuticalized “care.” Subst Use Misuse 2018;53:301–10.

   OpenUrl
8. 8.↵
   1. Fox AD,
   2. Masyukova M,
   3. Cunningham CO

   . Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients' experiences and preferences. Substance Abuse 2016;37:70–5.

   OpenUrl
9. 9.↵
   1. McElrath K

   . Medication-Assisted treatment for opioid addiction in the United States: critique and commentary. Substance Use Misuse 2018;53:334–43.

   OpenUrl